Celgene Corporation News
Credits & Debits | email@example.com
Caution has clearly been the fool's way in this market.
Celgene Corporation was a winner within the health care sector, rising $1.43 (1.2%) to $124.91 on average volume
Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to InvestingMay 17
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."
TheStreet Ratings group highlights 5 stocks pushing the health care sector lower today.